Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-a Cancer Journal for Clinicians. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14(1):33–41.

Article  PubMed  PubMed Central  Google Scholar 

Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L. Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial. Cancer Cell. 2022;40(3):277–88.

Article  PubMed  Google Scholar 

Liu Y, Ren Z, Yuan L, Xu S, Yao Z, Qiao L, Li K. Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer. Am J Cancer Res. 2016;6(10):2345.

PubMed  PubMed Central  Google Scholar 

Zhou J, Wu Z, Wong G, Pectasides E, Nagaraja A, Stachler M, Zhang H, Chen T, Zhang H, Liu JB, Xu X. CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. Nature Commun. 2017;8(1):13897.

Article  Google Scholar 

Chong CR, Jänne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med. 2013;19(11):1389–400.

Article  PubMed  PubMed Central  Google Scholar 

Yamamoto S, Kato K. JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma. Cancer Cell. 2022;40(3):238–40.

Article  PubMed  Google Scholar 

Liu Z, Zhang Y, Ma N, Yang Y, Ma Y, Wang F, Wang Y, Wei J, Chen H, Tartarone A, Velotta JB. Progenitor-like exhausted SPRY1+ CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell. 2023;41(11):1852–70.

Article  PubMed  Google Scholar 

Eyck BM, van Lanschot JJ, Hulshof MC, van der Wilk BJ, Shapiro J, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, van Laarhoven HW, Nieuwenhuijzen GA, Hospers GA. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39(18):1995–2004.

Article  PubMed  Google Scholar 

Liu SL, Wen J, Yang H, Li QQ, Chen YP, Zhu CC, et al. Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010. Eur J Cancer. 2020;138:113–21.

Article  PubMed  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403.

Article  PubMed  Google Scholar 

Kang JH, Zappasodi R. Modulating Treg stability to improve cancer immunotherapy. Trends in Cancer. 2023;9(11):911–27.

Article  PubMed  Google Scholar 

van Hooren L, Handgraaf SM, Kloosterman DJ, Karimi E, van Mil LW, Gassama AA, Solsona BG, de Groot MH, Brandsma D, Quail DF, Walsh LA. CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma. Nature Cancer. 2023;4(5):665–81.

Article  PubMed  PubMed Central  Google Scholar 

Glasner A, Rose SA, Sharma R, Gudjonson H, Chu T, Green JA, Rampersaud S, Valdez IK, Andretta ES, Dhillon BS, Schizas M. Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies. Nat Immunol. 2023;24(6):1020–35.

Article  PubMed  PubMed Central  Google Scholar 

van Gulijk M, van Krimpen A, Schetters S, Eterman M, van Elsas M, Mankor J, Klaase L, de Bruijn M, van Nimwegen M, van Tienhoven T, van Ijcken W. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science Immunology. 2023 May 19;8(83):eabn6173. https://doi.org/10.1126/sciimmunol.abn6173

Gohil SH, Iorgulescu JB, Braun DA, Keskin DB, Livak KJ. Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy. Nat Rev Clin Oncol. 2021;18(4):244–56.

Article  PubMed  Google Scholar 

Ren X, Zhang L, Zhang Y, Li Z, Siemers N, Zhang Z. Insights gained from single-cell analysis of immune cells in the tumor microenvironment. Annual Review Immun. 2021;39(1):583–609.

Article  Google Scholar 

Bassez A, Vos H, Van Dyck L, Floris G, Arijs I, Desmedt C, Boeckx B, VandenBempt M, Nevelsteen I, Lambein K, Punie K. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nature Med. 2021;27(5):820–32.

Article  PubMed  Google Scholar 

Goswami S, Walle T, Cornish AE, Basu S, Anandhan S, Fernandez I, Vence L, Blando J, Zhao H, Yadav SS, Ott M. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma. Nature Med. 2020;26(1):39–46.

Article  PubMed  Google Scholar 

Hong N, Sun G, Zuo X, Chen M, Liu L, Wang J, et al. Application of informatics in cancer research and clinical practice: opportunities and challenges. Cancer Innov. 2022;1(1):80–91.

Article  PubMed  PubMed Central  Google Scholar 

Buchan NS, Rajpal DK, Webster Y, Alatorre C, Gudivada RC, Zheng CY, et al. The role of translational bioinformatics in drug discovery. Drug Discovery Today. 2011;16(9–10):426–34.

Article  PubMed  Google Scholar 

Xie F, Zhang JJ, Wang JY, Reuben A, Xu W, Yi X, et al. Multifactorial deep learning reveals pan-cancer genomic tumor clusters with distinct immunogenomic landscape and response to immunotherapy. Clin Cancer Res. 2020;26(12):2908–20.

Article  PubMed  PubMed Central  Google Scholar 

Kumari S, Rehman A, Chandra P, Singh KK. Functional role of SAP18 protein: from transcriptional repression to splicing regulation. Cell Biochem Funct. 2023;41(7):738–51.

Article  PubMed  Google Scholar 

Wu C, Li JJ, Tian CC, Shi W, Jiang HM, Zhang Z, et al. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis. BBA-Mol Basis Dis. 2018;1864(8):2511–25.

Article  Google Scholar 

Varier KM, Dan G, Liu W, Wu G, Xiao C, Lei H, Ling T, Jiang Y, Chen Y, Ben-David Y, Li Y. Stilbene B10 induces apoptosis and tumor suppression in lymphoid Raji cells by BTK-mediated regulation of the KRAS/HDAC1/EP300/PEBP1 axis. Biomed Pharmacother. 2022;1(156):113887.

Article  Google Scholar 

Palanikumar L, Al-Hosani S, Kalmouni M, Nguyen VP, Ali L, Pasricha R, Barrera FN, Magzoub M. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun Biol. 2020;3(1):95.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Huang F, Zhao J, Huang P, Tan J, Huang M, Ma R, Xiao Y, He S, Wang Z, Shen J. Tumor-infiltrated CD8+ T Cell 10-gene signature related to clear cell renal cell carcinoma prognosis. Frontiers Immun. 2022;24(13):930921.

Article  Google Scholar 

Han X, Shi H, Sun Y, Shang C, Luan T, Wang D, Ba X, Zeng X. CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3. Cell Death Dis. 2019;10(8):598.

Article  PubMed  PubMed Central  Google Scholar 

Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–8.

Article  PubMed  PubMed Central  Google Scholar 

Huang R, Zhou L, Chi Y, Wu H, Shi L. LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer. Biomarker Res. 2020;8:1–6.

Article  Google Scholar 

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1–21.

Article  Google Scholar 

Ritchie ME, Phipson B, Wu DI, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.

Article  PubMed  PubMed Central  Google Scholar 

Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–56.

Article  PubMed  PubMed Central  Google Scholar 

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–62.

Article  PubMed